Fundraising FoxFluxion
Acquired5 known investors
Find your way into Fluxion
Sign up to see every warm intro you have to Fluxion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fluxion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cell Microsystems develops laboratory instruments and platforms for cell engineering, culture, isolation, and analysis, including single-cell sorting, 3D cell culture, cell counting, tissue dissociation, and automated electrophysiology. Its tools serve life-science researchers and biopharma labs working on cell line development, drug discovery, and organoid/stem cell research.
Investors · 5
How we know: Claremont Creek Ventures's portfolio page · Not right? Tell us
How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $308.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $284.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $355K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2009 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $203.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $117.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2007 | $636K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2005 | $101.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Fluxion do?
- Cell Microsystems develops laboratory instruments and platforms for cell engineering, culture, isolation, and analysis, including single-cell sorting, 3D cell culture, cell counting, tissue dissociation, and automated electrophysiology. Its tools serve life-science researchers and biopharma labs working on cell line development, drug discovery, and organoid/stem cell research.
- Who are Fluxion's investors?
- Fluxion's investors include Claremont Creek Ventures, Mission Bay Capital, Mission Biocapital, Signet Healthcare Partners, Western Technology Investment.